fasudil has been researched along with Granulomas in 1 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, W | 1 |
| Yang, Y | 1 |
| Mei, C | 1 |
| Dong, P | 1 |
| Mu, S | 1 |
| Wu, H | 1 |
| Zhou, Y | 1 |
| Zheng, Y | 1 |
| Guo, F | 1 |
| Yang, JQ | 1 |
1 other study available for fasudil and Granulomas
| Article | Year |
|---|---|
Inhibition of Rho-Kinase Downregulates Th17 Cells and Ameliorates Hepatic Fibrosis by
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Cell Differentiation; Collagen Type I; Femal | 2019 |